Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...
8h
LGBTQ Nation on MSNOnce-a-year shot for HIV protection passes early safety trialAn annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...
14h
Clinical Trials Arena on MSNViiV to trial twice-yearly HIV antibody dosing after Phase IIb successThe company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Reuters reviewed a copy of a 368-page document that showed the most extensive list to date of the thousands of USAID programs ...
Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...
A groundbreaking SAMRC study has uncovered significant underreporting of HIV-related deaths in South Africa, despite the ...
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
FEAR AND ANXIETY' Kenya has the seventh-largest number of people living with HIV in the world, at around 1.4 million, according to World Health Organization data. The President's Emergency Plan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results